Breakthrough gene therapy offers hope for Duchenne muscular dystrophy

FHS
July 18, 2024
11:21 am

A new gene therapy treatment for Duchenne muscular dystrophy shows promise of not only arresting the decline of the muscles of those affected by this inherited genetic disease, but perhaps, in the future, repairing those muscles.

SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations – Biotech Investments

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Personnel SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations 30.04.2024 / 17:00 CET/CEST

May 1, 2024

5 Ways Federated Computing Can Reshape Public Health

Unlocking data silos using Federated Computing (FC) has the potential to achieve a positive impact across the healthcare industry, ranging from clinical care quality improvement

October 2, 2023

Neuro startup stock craters after PhIII study marred with ‘significant deviation’ from trial protocol

A Nevada startup researching an Alzheimer’s drug saw its stock crater Wednesday morning after it reported Phase III results that included data integrity issues at

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.